DHX Company Co., Ltd. (KOSDAQ:031860)

South Korea flag South Korea · Delayed Price · Currency is KRW
484.00
-22.00 (-4.35%)
At close: Feb 13, 2026
Market Cap9.19B -60.9%
Revenue (ttm)16.38B +122.5%
Net Income-22.28B
EPS-1,305.72
Shares Out18.98M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,043,034
Average Volume482,745
Open506.00
Previous Close506.00
Day's Range398.00 - 509.00
52-Week Range398.00 - 1,783.00
Beta0.23
RSI30.35
Earnings DateMar 20, 2026

About DHX Company

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset ma... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1979
Employees 23
Stock Exchange KOSDAQ
Ticker Symbol 031860
Full Company Profile

Financial Performance

In 2024, DHX Company's revenue was 9.54 billion, a decrease of -14.28% compared to the previous year's 11.13 billion. Losses were -17.59 billion, -44.57% less than in 2023.

Financial Statements